Ziprasidone Hydrochloride (Avera McKennan Hospital)
Welcome to the PulseAid listing for the Ziprasidone Hydrochloride drug offered from Avera McKennan Hospital. This Atypical Antipsychotic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Avera McKennan Hospital |
NON-PROPRIETARY NAME: | ziprasidone hydrochloride |
SUBSTANCE NAME: | ZIPRASIDONE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Atypical Antipsychotic [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2016-07-07 |
END MARKETING DATE: | 0000-00-00 |
Ziprasidone Hydrochloride HUMAN PRESCRIPTION DRUG Details:
Item Description | Ziprasidone Hydrochloride from Avera McKennan Hospital |
LABELER NAME: | Avera McKennan Hospital |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 60(mg/1) |
START MARKETING DATE: | 2016-07-07 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 69189-7352_4738c249-ee2a-42c2-a3aa-cbf584f6ef99 |
PRODUCT NDC: | 69189-7352 |
APPLICATION NUMBER: | ANDA202395 |
Other ZIPRASIDONE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: